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Many bacterial species use cyclic diguanylate (c-di-GMP) to control their physiology and
behaviors in response to extracellular stimuli. C-di-GMP primarily mediates the switch
between a free-living, motile state and a nonmotile lifestyle, with the latter often entailing sur-
face adherence and biofilm development [1, 2]. This paradigm is conserved across diverse
gram-positive and gram-negative species, though the specific extracellular signals that impact
c-di-GMP levels and the response mechanisms employed vary. Because c-di-GMP affects
motility and adherence, it consequently can influence bacterial pathogenicity [3]. In addition,
a number of pathogenic bacteria have engaged c-di-GMP signaling to control specific viru-
lence mechanisms, including effector secretion mechanisms and toxin biosynthesis [4–7].
How are intracellular c-di-GMP levels controlled?
The extracellular signals that influence bacterial c-di-GMP metabolism are largely undefined.
Salmonella enterica serovar Typhimurium alters its c-di-GMP content in response to glucose,
N-acetylglucosamine, sialic acid, or arginine [8]. Genetic evidence indicates that Vibrio cho-
lerae reduces its intracellular c-di-GMP levels upon infection of the small intestine [4, 9], and
bile and bicarbonate provide physiologically relevant host cues to regulate c-di-GMP levels
[10]. In Clostridioides difficile (also Clostridium difficile), at least one c-di-GMP hydrolytic
enzyme, PdcA, is induced in response to nutrient limitation through the nutrient-responsive
transcriptional regulator CodY present in many gram-positive species [11].
In response to extracellular stimuli, bacteria alter intracellular c-di-GMP concentrations
through the opposing activities of diguanylate cyclases (DGCs) that synthesize c-di-GMP from
guanosine triphosphate (GTP), and phosphodiesterases (PDEs) that hydrolyze c-di-GMP.
Many bacteria, particularly the Gammaproteobacteria, encode numerous DGCs and PDEs [1].
Changes in c-di-GMP thus are likely accomplished by adjusting the production, activity, or
localization of these enzymes so that only a subset of the enzymes function under a particular
environmental condition. C. difficile strain 630 encodes 18 confirmed or putative DGCs and
17 confirmed or putative PDEs [12, 13]. Most of the enzymes are predicted to be membrane-
localized, and several contain additional domains that may modulate enzymatic activity [12].
If and how these features impact c-di-GMP synthesis and hydrolysis is difficult to predict and
must be determined experimentally. PdcA, for example, contains a PAS domain that is
required for c-di-GMP hydrolysis and is postulated to be involved in nutrient sensing [11].
How are changes in intracellular c-di-GMP levels sensed?
C-di-GMP levels are sensed by specific intracellular receptors. Several protein sensors of c-di-
GMP have been identified (reviewed in [14]), and the regulatory consequence of c-di-GMP
binding is determined by features of the specific receptor protein. For instance, c-di-GMP–
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responsive transcription factors show altered DNA binding capacity in response to the ligand,
resulting in changes in gene expression. Other c-di-GMP receptors act posttranslationally to
modulate the activity of other proteins or protein complexes, such as the PilZ domain proteins
that inhibit swimming motility by interfering with flagellar motor function [15, 16].
Many bacteria encode RNA-based c-di-GMP sensors. Riboswitches are encoded in the 50
leader sequence (untranslated region [UTR]) of some messenger RNAs (mRNA), and they
fold to adopt a structure that binds a specific ligand [17]. Ligand binding by the nascent
mRNA causes the formation of an alternate, mutually exclusive structure and typically affects
whether the downstream genes are expressed or translated. For example, ligand binding can
affect the formation of an intrinsic transcription terminator within the 50 UTR, determining
whether the downstream gene is transcribed (Fig 1). Alternatively, the RNA structure assumed
can affect the accessibility of the ribosome binding site, influencing translation of the down-
stream coding sequence. Depending on the specific riboswitch and its genetic context,
Fig 1. Model for c-di-GMP mediated transition between free-living, toxin producing state and an adherent state in
Clostridium difficile. (Left) Under low intracellular c-di-GMP conditions, the Cd1 “off” riboswitch forms a structure conducive to
transcription of the downstream flgB operon. The Cdi-2-4 “off” riboswitch assumes a structure that includes a transcription
terminator, precluding transcription of downstream TFP genes. Therefore, low c-di-GMP favors flagellated, swimming bacteria
that also produce the glucosylating toxins TcdA and TcdB. (Right) Elevated intracellular c-di-GMP (represented by black dots)
results in ligand binding to the Cd1 and Cdi-2-4 riboswitches, causing mRNA conformations that terminate transcription of the
flgB mRNA but promote transcription read-through of pilA1 and downstream TFP genes. High c-di-GMP thus results in
nonflagellated, nontoxigenic, piliated bacteria with increased adherence properties. Presumably intermediate c-di-GMP
concentrations exist that result in bacteria with both flagella and TFP. (Insets) Transmission electron micrographs and graphical
depictions of C. difficile 630Δerm with basal c-di-GMP resulting in flagellated, toxin-secreting bacteria (left) or elevated c-di-GMP
resulting in nontoxigenic bacteria bearing Type IV pili (right). Toxins TcdA and TcdB are represented by red and orange symbols.
Cd1, flgB riboswitch; Cdi-2-4, pilA1 riboswitch; c-di-GMP, cyclic diguanylate; mRNA, messenger RNA; TFP, type IV pili.
https://doi.org/10.1371/journal.ppat.1007529.g001
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riboswitches can act as “on” or “off” switches in response to ligand binding, promoting or pre-
venting gene expression, respectively. Two classes of c-di-GMP specific riboswitches have
been identified: class I and class II [18, 19]. Typically, riboswitches bind ligands that are the
products of the regulated pathway, serving as feedback mechanisms for that metabolite. The c-
di-GMP riboswitches are unusual in that they rarely control c-di-GMP metabolic genes.
Instead, c-di-GMP riboswitches are encoded upstream of genes known or predicted to be
involved in motility, chemotaxis, adherence, or other processes that are often targets of c-di-
GMP regulation. In fact, the class I riboswitches are also termed genes for the environment,
membranes and motility (GEMM) riboswitches, for reflecting this conserved function of c-di-
GMP riboswitches [20].
How do class I and class II riboswitches respond to c-di-GMP?
Only a small subset of c-di-GMP riboswitches have been validated [18, 19, 21–26], and even
fewer have been studied in their native genetic context. The best studied system occurs in the
gram-positive bacterium Clostridium difficile, a major cause of antibiotic-associated, cyto-
toxin-mediated diarrhea in humans. C. difficile possesses a particularly large number of c-di-
GMP riboswitches. The C. difficile 630 genome contains 12 class I and 4 class II c-di-GMP
riboswitches [18, 19]. Only 11 of the riboswitches are functional, i.e., the expression of the
downstream genes is regulated by c-di-GMP [25, 26]. These functional riboswitches are highly
conserved across C. difficile strains, unless the regulated genes are also absent; the nonfunc-
tional riboswitches are less well-conserved [26]. In C. difficile, the seven functional class I
riboswitches are uniformly “off” switches, with elevated c-di-GMP triggering transcription ter-
mination and precluding expression of the downstream genes. Conversely, the four class II
riboswitches are “on” switches, with elevated c-di-GMP favoring gene expression. However, in
the soil-dwelling, gram-positive bacterium Bacillus thuringiensis, the class I riboswitch Bc2
acts as an “on” switch by promoting transcription read-through of the cap gene encoding col-
lagen adhesion protein [27]. The gram-negative Vibrio cholerae encodes two class I c-di-GMP
riboswitches that respond to the ligand in opposing directions, and neither function by con-
trolling transcription termination [21, 22]. Therefore, regulatory attributes cannot necessarily
be extrapolated to c-di-GMP riboswitches in other bacterial species but must be evaluated in
each context.
How does c-di-GMP signaling through riboswitches impact
pathogenesis?
Because its genome contains a large number of c-di-GMP riboswitches regulating genes with
measurable phenotypes, C. difficile serves as an excellent model for understanding how c-di-
GMP riboswitches function in vivo. C. difficile produces peritrichous flagella that are involved
in motility and intestinal colonization [28]. As in other species, flagellar gene expression is
coordinated in a hierarchical manner, and “early stage” flagellar genes are coexpressed as part
of the 23 kb flgB operon. A class I riboswitch, Cd1 (also named Cdi-1-3), lies in the 50 UTR of
the flgB operon (Fig 1) [18]. Initial studies using reporter fusions to the riboswitch region,
assayed in Escherichia coli, indicated that Cd1 functions as an “off” switch in response to c-di-
GMP [18]. Consistent with this, in vitro transcription assays showed that c-di-GMP increased
the appearance of a terminated product in a dose-dependent manner [18]. Subsequent work in
C. difficile demonstrated that increasing intracellular c-di-GMP inhibits flgB operon expres-
sion [29], and a truncated RNA corresponding to the riboswitch-mediated termination prod-
uct was detected by northern blot [25, 30]. Consistent with “off” function, c-di-GMP inhibits
flagellum biosynthesis and swimming motility of C. difficile [29]. Expression of the genes
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encoding the glucosylating toxins that are essential for disease development, tcdA and tcdB, is
linked to flagellar gene expression [31]. The sigma factor SigD not only coordinates flagellar
gene transcription but also activates transcription of tcdR, which encodes another sigma factor
required for tcdA and tcdB expression. The sigD gene is encoded within the flgB operon, and
its expression is therefore controlled by c-di-GMP via the Cd1 riboswitch [29]. Accordingly, c-
di-GMP indirectly inhibits expression of tcdR, tcdA, and tcdB, resulting in reduced toxin pro-
duction and cytotoxicity [5]. These findings suggest that c-di-GMP must be sufficiently low to
allow motility and toxin production by C. difficile during infection.
In contrast, c-di-GMP production must be upregulated to stimulate adherent behaviors. C.
difficile produces type IV pili (TFP) that contribute to autoaggregation, biofilm formation,
adherence to epithelial cells, and persistence in a mouse model of infection [23, 32, 33]. C-di-
GMP promotes the expression of TFP genes via a class II riboswitch upstream of pilA1, which
encodes the major pilin subunit of TFP (Fig 1) [23]. This riboswitch, Cdi-2-4, assumes a struc-
ture in the presence of c-di-GMP that allows transcription of the pilA1 coding sequence, as
well as some read-through of the downstream pilB operon encoding other TFP components.
In the absence of c-di-GMP, Cdi-2-4 folds to induce transcription termination, thus prevent-
ing TFP gene expression, biosynthesis, and adherence.
Additionally, the expression of CD630_28310 and CD630_32460 is also positively regulated
by c-di-GMP via class II riboswitches, Cdi-2-3 and Cdi-2-1, respectively [19, 24]. These genes
encode sortase-dependent surface proteins that are predicted to act as adhesins [19, 24, 34].
Notably, the zinc-dependent metalloprotease ZmpI (also named Pro-Pro endopeptidase
PPEP-1) cleaves the CD630_28310 and CD630_32460 proteins near their cell wall anchor
motifs, releasing them from the bacterial surface [35]. A C. difficile zmpI mutant is attenuated
in a hamster model of infection [34], presumably because it is defective for release of
CD630_28310 and/or CD630_32460 from the cell surface. The zmpI mRNA (CD630_28300)
contains a class I riboswitch and is negatively regulated by c-di-GMP. The opposing regulation
of ZmpI and its surface protein targets has been proposed to integrate increased c-di-GMP to
simultaneously promote production of the surface proteins and inhibit their release by ZmpI
[36]. Together these studies indicate that, as in other bacterial species, C. difficile uses c-di-
GMP to regulate the transition between motile and nonmotile lifestyles and to control viru-
lence factors.
What can we learn about c-di-GMP signaling by studying c-di-GMP
riboswitches?
C. difficile appears to rely primarily on c-di-GMP riboswitches rather than protein sensors,
presenting opportunities to address outstanding questions in c-di-GMP signaling. For exam-
ple, given multiple physiological targets in a single bacterial species, how is c-di-GMP regula-
tion coordinated? C-di-GMP riboswitches in C. difficile appear to display a range of response
kinetics to c-di-GMP, suggesting hierarchical activation or inhibition of gene expression from
given changes in c-di-GMP [26]. The set of riboswitches found in a single species provides a
means to test as proof-of-principle that different intracellular concentrations of c-di-GMP trig-
ger specific responses. A hierarchical response to c-di-GMP is supported by a recent study
measuring the transcription of riboswitch-regulated genes to increasing intracellular c-di-
GMP [26]. Additionally, given the pleiotropic role of c-di-GMP, how is its control of individ-
ual phenomena achieved? Riboswitch-mediated regulation occurs in cis, so defined mutations
in riboswitches that prevent c-di-GMP binding would allow targeted abrogation of regulated
outcomes. Riboswitches are also being implemented as biosensors in a number of systems to
measure native c-di-GMP levels under different growth conditions [32, 37, 38]. This approach
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offers greater sensitivity than quantification of c-di-GMP in cellular extracts, as well as the abil-
ity to examine c-di-GMP on a single-cell basis rather than in the bulk population. The avail-
ability of “on” and “off” riboswitches with characterized (and alterable) affinities for c-di-GMP
may provide modular systems that can be utilized as biosensors in a wide range of bacterial
species.
Finally, a number of other pathogenic bacteria encode putative c-di-GMP riboswitches [18,
19]. Vibrio parahaemolyticus and V. vulnificus encode homologues of Vc1 and Vc2 from V.
cholerae upstream of the gbpA and tfoX orthologues, respectively. Bacillus anthracis encodes a
c-di-GMP riboswitch upstream of a putative methyl accepting chemotaxis protein, suggesting
a role in chemotaxis and motility. The opportunistic pathogen Aeromonas hydrophila encodes
c-di-GMP riboswitches upstream of putative fimbrial and chitinase genes, implying roles in
adherence. The Clostridium tetani and C. perfringens genomes contain multiple c-di-GMP
riboswitches, including upstream of orthologous genes encoding a predicted collagen binding
domain. Additional work is needed to elucidate the role of c-di-GMP riboswitches in modulat-
ing the physiology and behavior of bacterial pathogens.
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